+33(0)1 42 54 60 64 | contact@welcomeurope.com

Login

Twinning Instrument – Support for capacity development of the National Agency of Pharmaceutical Products – 2022

Twinning Instrument - Support for capacity development of the National Agency of Pharmaceutical Products, aiming at implementing the national policy of the pharmaceutical industry, particularly in its aspects related to patient safety, the preservation of public health and the development of industries in the pharmaceutical sector.

2022-08-11
1.150 million euro
Open

Appeal framework

Sectors Citizenship & Human Rights Civil Protection & Risks Cooperation & Development Health
Beneficiaries All beneficiaries Association & NGO EU & International Organisation
Regions European Union, Mediterranean countries
Details

Actions must be carried out in Algeria.

Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

Objectives

  • Support the implementation of the pharmaceutical policy set up by the Ministry of Pharmaceutical Industry
  • Improvement of health safety by strengthening the existing system in order to guarantee the quality, safety and efficacy of pharmaceutical products and medical devices as well as their performance in order to preserve public health
  • Strengthen the capacities of the National Agency for Pharmaceutical Products to ensure its new missions of evaluation, audit, inspection and control of the quality and safety of pharmaceutical products and the performance of medical devices

Priorities

  • Priority 1: Access to health
  • Priority 2: Building a resilient infrastructure, promoting sustainable industrialisation that benefits all and fostering innovation and fostering innovation
  • Priority 3: Responsible consumption and production

Among financed actions

  • Organisational strengthening through, in particular, the managerial, technical and scientific component
  • Modernisation of the ANPP’s communication in order to better exchange with pharmaceutical operators and the general public
  • The improvement of coordination between the different directorates of the Agency and the fluidity of the dissemination of information internally
  • The modernisation of the registration process of pharmaceutical products and the approval of medical devices for which online access has been set up
  • Upgrading to Good Pharmaceutical Practice standards and on-site audits and inspections

Additional information

  • This call for proposals is an open call for proposals
  • Initial duration of the action: 24 months

Eligibility

  • The Member State Project Leader must be a high-ranking civil servant of the twinning Administration or an assimilated agent of a fully mandated body able to ensure an operational dialogue at the political level for the fulfilment of the objectives and able to solve problems with adequate solutions
  • The Resident Twinning Advisor is a civil servant or employee of an institution or mandated body of the Member State for less than 3 years, s/he will ensure the twinning project implementation for the duration of the twinning
  • For applicants from the United Kingdom: references to natural or legal persons residing or established in a Member State of the European Union and to goods originating in an eligible country, within the meaning of Regulation (EU) No 236/2014 and Annex IV of the ACP-EU Partnership Agreement, should be understood as including natural or legal persons residing or established in the United Kingdom and goods originating in the United Kingdom. Such persons and goods are therefore eligible under this call.
Financement

Test your eligibility

Other funds:

FEDER
FSE+
HORIZON EUROPE
FEDER
FSE+
HORIZON EUROPE

Similar news

25 August 2021

Webinar Horizon Europe: Guide to prepare an accurate financial statement on time

Read the article

9 June 2021

Welcomeurope’s new service!

Read the article